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Abstract
Objective—To describe service utilization of a cohort of children with emotional and behavioral
disorders who visited outpatient mental health clinics in four Midwest cities.
Method—Data come from the Longitudinal Assessment of Manic Symptoms (LAMS) Study.
707 youth (ages 6–12 years) and their parents completed diagnostic assessments, demographic
information and an assessment of mental health service utilization. Analyses examined the
relationship of demographics, diagnoses, impairment, and comorbidity to the type and level of
services utilized.
Results—Service utilization is multimodal with half of the youth receiving both outpatient and
school services during their lifetime. Non-need factors including age, sex, race, and insurance,
were related to types of services used. Youth diagnosed with a bipolar spectrum disorder had
higher utilization of inpatient services and two or more services at one time compared to youth
diagnosed with depressive or disruptive disorders. More than half of youth diagnosed with bipolar
or depressive disorders had received both medication and therapy during their lifetime whereas for
youth diagnosed with a disruptive disorder therapy only was more common. Impairment and
comorbidity were not related to service utilization.
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Conclusions—Use of mental health services for children begins at a very young age and occurs
in multiple service sectors. Type of service use is related to insurance and race/ethnicity,
underscoring the need for research on treatment disparities. Contrary to findings from results
based on administrative data, medication alone was infrequent. However, the reasonably low use
of combination therapy suggests that clinicians and families need to be educated on the
effectiveness of multimodal treatment.
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An estimated 2.7 million children in the United States suffer from severe mental illness and
mental illness causes significant impairment in 3% to 18% of children and adolescents (1–
2). However, data from community-based studies document that children with impairing
mental illnesses receive no services or only services in the educational system (3–4). When
youth interact with multiple service sectors these sectors frequently do not work together to
form a comprehensive treatment approach, and services are often inadequate to address
symptoms and impairment (5–6).
Little information exists about utilization and barriers specific to individual diagnoses,
although data suggest that having a disruptive disorder is significantly associated with
children's use of mental health services, but having a depressive disorder is not (7–8). Few
studies have investigated service utilization of children diagnosed with more serious
disorders such as bipolar disorder and psychosis. Examination of MEDSTAT’s MarketScan
data for 1993 and 1996 found that youth receipt of mental health services fell from 4.2% to
3.0% (9). Frequency of specific diagnoses differed by service setting. Major depression/
bipolar, other mental health diagnoses, and mild/moderate depression were most common in
inpatient settings while hyperactivity, other mental health diagnoses, and adjustment
reaction disorder were most common in outpatient settings. Similar analyses of MarketScan
data from 1997 to 2000 found that the overall distribution of diagnoses changed little from
1997 to 2000 for hyperactivity, depressive disorders, adjustment disorders and other mental
health disorders but significantly increased for bipolar disorders, schizophrenia, and anxiety
disorders (10).
Despite its low prevalence, bipolar disorder is associated with a disproportionate use of
health services and significantly higher costs driven by more use of inpatient hospitalization
(11). A study examining individuals with insurance claims in 1996 found nearly half (40%)
of the adolescents diagnosed with bipolar disorder had at least one inpatient hospitalization
within the year. Half of those (20%) had more than one inpatient hospitalization within the
year. Almost 25% of those < 21 years exceeded 20 outpatient visits, and almost 50% of the
hospitalized adolescents exceeded 30 inpatient days (12). Similarly, in the Course and
Outcome of Bipolar Illness in Youth (COBY) study, approximately 80% of the youth
diagnosed with bipolar disorder used services over a six month period. Sixty seven percent
used outpatient services, 22%, inpatient/partial hospitalization services, and 12%,
residential/therapeutic school-based services. Predictors of high levels of care included older
age, female sex, greater symptom severity, and rapid cycling. Predictors of more restrictive
treatment settings included suicidal and self-injurious behavior, comorbid conduct disorder,
and parental substance use disorders (13).
These studies suggest mental health service utilization patterns differ in important ways by
diagnosis, and specific attention needs to be focused on the most severe disorders, both
because of the paucity of information but also because these youth use the majority of
services, particularly costly services such as hospitalization (11–12).
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The purpose of the current study is to describe service utilization by demographics and
diagnoses for a cohort of children with emotional and behavioral disorders who were first
time users of participating outpatient mental health clinics in four major Midwest cities. The
current analyses contribute to the scant literature on children’s mental health service
utilization by: (1) focusing on service use by a unique outpatient clinic population; (2)
examining various types of services at all levels of care; and (3) exploring patterns of service
utilization in the context of diagnosis. Specifically, we tested the hypothesis: Demographic
characteristics (sex [male], age [older], race [White] and insurance coverage [private
insurance]) and clinical characteristics (major mental illness, comorbid diagnoses, more
impairment) will be related to utilization of more services and higher intensity services.
Method
Sample
The source population consisted of all children between 6 years and 12 years 11 months on
their first visit to child outpatient clinics associated with the four LAMS university partners
(one child turned 13 between the screening and baseline assessment). Parents or guardians
accompanying eligible children were approached using procedures approved by each
university’s and/or hospital’s Institutional Review Board. After consenting, the adults were
asked to complete the Parent General Behavior Inventory-10 Item Mania Scale
(PGBI-10M), in addition to sociodemographic questions (14). Of 3329 study families
visiting the participating outpatient clinics, 2622 (79%) agreed to be screened. Results
indicated nearly half 1124 (43%) scored above the a priori cut-off for manic symptoms
(positive for ESM or ESM+). Of those with ESM+, 1111 were eligible for the longitudinal
follow-up portion of the study (13 were ineligible due to parent report of a diagnosis of
Autism/PDD, IQ <70) and of these, 621 parent/child dyads agreed to participate.
For every 10 ESM+ children, one ESM− child was selected as a potential comparator. Using
minimization methods, controls were selected to match the “modal” positive child in the
time segment (15). Eighty-six ESM− parent/child dyads agreed to participate. The design
and sample selection as well as sociodemographic data on all children screened have been
previously described (16). Families who agreed to participate in the longitudinal portion of
the study were scheduled for a baseline interview, the clinical highlights of which are
described elsewhere (17).
Measures
Demographics—Demographics including child age, sex, race, ethnicity, and insurance
status were collected as well as family demographic information such as family
composition, socio-economic status, and parents’ education and employment.
Kiddie Schedule for Affective Disorders and Schizophrenia for School-Age
Children-Present and Lifetime Episode supplemented with additional mood
onset and offset items (K-SADS-PL-W)—To assess for current and past psychiatric
disorders, children and their guardians were administered the Schedule for Affective
Disorders and Schizophrenia for School Age Children- Present and Lifetime episode
(KSADS-PL) supplemented with additional mood onset and offset items from the WASH-
U-K-SADS (18–19). Additionally, DSM-IV items screening for pervasive developmental
disorders (PDDs) were added. Diagnoses were grouped into hierarchical categories: bipolar
spectrum disorder, depressive disorder, psychotic disorder, anxiety disorder, disruptive
behavior disorders, pervasive developmental disorders, other, and no diagnosis. The
hierarchical order was designed to provide clarity about the status and evolution on the
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mood spectrum, which is the main area of investigation in the LAMS study. Children with
comorbidities were only counted in the diagnostic category highest in the hierarchy.
Children’s Global Assessment Scale (CGAS)—The CGAS documents children’s
overall level of functioning at home, school, and with peers (20). Scores range from 1 to 100
with lower scores indicating more significant impairment. Interviewers completed ratings
for the child’s current functioning (past two weeks) and for the most severe past episode of
psychiatric illness. Children were divided into two impairment groups; those with a CGAS
score less than 51 (indicative of major impairment) and those with CGAS scores greater
than or equal to 51 (mild impairment).
Services Assessment of Children and Adolescents (SACA)—The parent version
of the SACA gathers information about the use of various mental health services for the
child in three broad domains: inpatient, outpatient, and school. The SACA was used at the
baseline assessment to collect information on lifetime and current service utilization from
parent report (21).
Analyses
Descriptive statistics, including means and percentages, described the demographic, clinical,
and service variables. Chi-square analyses evaluated associations among categorical
variables (or Fisher’s exact test when cells showed low expected frequencies). Logistic
regression analyses evaluated the relationships of demographic characteristics to lifetime
hospitalization and utilization of specific treatments at baseline. Analyses were conducted
with SAS version 9.2.
Results
Sample Characteristics
The sample has been previously described (16–17). Briefly, two-thirds of the sample is male
(n=478, 68%) and White (n=455, 64%) with nearly half (n= 323, 45%) between the ages of
six and eight. Fifty-two percent had public insurance and 23% of the children had a primary
diagnosis within the bipolar spectrum. Sixty-three percent of the children had mild to
moderate functional impairment and 72% had taken psychotropic medications during their
lifetime.
Service Utilization
Over 11% of the sample reported lifetime use of intensive services (n=80; Table 1), most
commonly inpatient hospitalization (n=64, 9%). Ninety-eight percent had used outpatient
services with 58% (n=411) having consulted with a psychiatrist. School services (n=361,
51%) were most often special help in the regular classroom or counseling. Almost 50% of
the sample had received both outpatient and school mental health services. The mean ages at
which children began outpatient (M=6.3, SD=2.6) and alternative services (M=6.1, SD=2.8)
were lower than intensive (M= 7.4, SD= 2.3) and school services (M=7.0, SD=2.1).
Demographic/ Clinical Variables and Service Utilization
Bivariate analyses (Table 2) indicated that youth who were older, had lower CGAS scores
and more than one diagnosis were more likely to be hospitalized. Older youth (i.e., aged 11–
13) had more lifetime inpatient admissions and also had significantly more admissions in the
last year. A higher percentage of older youth (n=32; 18%) had utilized both intensive and
outpatient services during their lifetime compared to youth ages 6 to 8 (n=25, 8%) or 9 to 10
(n=21).
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For outpatient services, results indicated that youth were more likely to have had only
therapy in their lifetime if they were non-white, female, younger and insured by Medicaid
(Table 2). Analyses also indicated that youth were more likely to be receiving only
medications at baseline if they were male and were higher functioning according to the
CGAS. White children were more likely to have received both medications and therapy
sometime in their life compared to other races as were older children and children not
insured through Medicaid (χ2=14.02, p<.001). Children insured through Medicaid (n=88,
24%) were less likely to be utilizing two or more services compared to children with other
coverage (n=113, 33.5%).
Multivariate results (Table 3) indicated that, controlling for other demographic and clinical
variables and consistent with the bivariate results, older children with lower CGAS scores
were more likely to have ever been hospitalized. For treatment, receiving only therapy was
related to being non-White, female, younger and insured by Medicaid while receiving only
medication was more common if children were male (borderline) and had higher CGAS
scores. Lifetime use of combination therapy was more common for older children, those not
insured through Medicaid and those with lower CGAS scores.
Diagnosis and Impairment Associations with Service Utilization
Across diagnostic categories, children diagnosed with bipolar spectrum disorder had the
highest rates of lifetime inpatient admissions (n=36, 22%) and admissions in the past year
(n=22, 14%) (Table 4). Across diagnostic categories, neither presence of comorbidity nor
current level of functioning were significant factors for whether youth had lifetime or past
year inpatient hospitalizations.
For outpatient services, in both the bipolar spectrum group and the depressive disorder
group, more than half of the youth in each group had received both medication and therapy
during their lifetime (bipolar: n=90, 57%; depressive: n=68, 55%). However among children
in the disruptive behavior disorder group, more children had received therapy only (n=82,
40%) than both medication and therapy (n=75, 36%). Comorbidity and impairment did not
impact lifetime exposure to different outpatient treatments with one exception. Children in
the bipolar spectrum group with lower CGAS scores were more likely to have had only
medication compared to those with higher scores. Also, youth with bipolar spectrum
disorder and major functional impairment (n=32, 41%) were more likely to be utilizing at
least two services than youth with bipolar spectrum disorder and mild impairment (n=21,
26%).
Characteristics and Benefits of Treatment as reported by parents?
Of those children who had at least one lifetime inpatient hospitalization (n=65, 9%), the
mean number of hospitalizations was 2.3 (SD=3.1) (Table 5). Median length of stay for the
most recent inpatient hospitalization was five days and the most frequently reported type of
treatment was therapy only (n= 18, 28%) although many parents were unsure of treatments
received (n= 20, 31%) or did not report any treatment (n= 11, 17%). Parents of children
receiving medication only never reported their child benefited “a lot” from the treatment,
and only 57% (n=4) reported their child benefited “some.”Most of the parents of children
receiving therapy only or both medication and therapy reported their child benefited “some”
or “a lot” from the treatment (therapy only: n= 17, 94%; combination: n= 8, 89%).
For current outpatient treatment, children were seeing, on average, 1.2 professionals
(SD=0.8) and most often were receiving therapy only. Most parents of children receiving
medication only or both medication and therapy reported their child benefited “some” or “a
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lot” from the treatment (medication only: n=156, 83%, combination: n=92, 84%). Fewer
parents reported their child benefited “some” or “a lot” from therapy only (n= 165, 66%).
Discussion
Similar to previous findings, children most frequently utilized mental health services
through school and outpatient settings. Almost half of the youth had received both outpatient
and school services during their lifetime (3, 22).
Lower current levels of functioning and older age increased the likelihood that youth had
inpatient admissions, consistent with previous findings (13, 23). Even though the current
sample only included children ages 6 to 13, whereas other studies included adolescents,
older age increased the likelihood of hospitalization. As duration of illness continues
intensity of intervention often increases, more often leading to hospitalization. As
hypothesized, race was a significant factor in service utilization. Similar to past findings
(24), White children were more likely to have received both medication and therapy in their
lifetime whereas children from other racial groups were more likely to have only received
therapy- Children with Medicaid coverage were less likely to have received combination
treatment and more likely to have received therapy only compared to children with other
insurance coverage. Additionally, these children were less likely to be utilizing two or more
services than children with other coverage. Low household income and restrictions in
coverage may be preventing these youth from getting all needed services. Since Medicaid
reimbursement is low for physicians and clinics can charge for the actual costs of counseling
or therapy, therapy may be the first line intervention in this sample of children . Also,
cultural differences in attitudes towards mental illness and the appropriateness of specific
interventions may be influencing utilization patterns. Sex was not a significant factor in
inpatient service utilization but was for outpatient service utilization, where females were
more likely to be receiving therapy only and males were more likely to be receiving
medication only. Of note, research findings on the impact of sex on service utilization have
not been consistent (8, 23–24).
Youth diagnosed with a bipolar spectrum disorder had higher inpatient admissions in their
lifetime and in the last year compared to those diagnosed with depressive or disruptive
disorders. These results are consistent with past research, in which adolescents with
pediatric bipolar disorder had higher hospital admission rates and injury/overdose-related
medical visits compared to youth with other psychiatric disorders (11). In both the bipolar
spectrum group and the depressive disorder group, more than half of the youth in each group
had received both medication and therapy during their lifetime. However, among children in
the disruptive behavior disorder group, more children had received therapy only than both
medication and therapy. This finding suggests that clinicians are more likely to employ only
psychosocial interventions for strictly behavioral disorders. For those children with
uncomplicated oppositional defiant disorder and conduct disorder, this is consistent with
current treatment guidelines although combination approaches might be optimal for some
children with disruptive behavior disorders who do not respond to psychosocial
interventions or children with specific co-occurring disorders such as children with ADHD
and ODD/CD (25–28). For children with mood disorders, clinicians are more likely to pair
psychosocial interventions with medication, as indicated by treatment guidelines (29–31).
Contrary to our hypothesis, comorbidity and impairment were not associated with service
utilization in this sample. A possible explanation for this finding is that clinical need factors
are more important for initial entry into the service system than for remaining in the system.
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A more detailed investigation of characteristics of utilization of inpatient and outpatient
services revealed that even though only 9% of the sample had inpatient hospitalizations in
their lifetime, these youth tended to be hospitalized multiple times. Research suggests that
24% to 37% of youth will be readmitted to a psychiatric hospital within 1 year after
discharge with age, sex, clinical and family characteristics all being factors associated with
readmission (32). Interestingly, parents seemed to find therapy only and a combination of
medication and therapy as most beneficial to their child in inpatient settings. However, in
outpatient settings, parents rated medication only and a combination of medication and
therapy as more beneficial than therapy only. These results do not provide reasons for
parents’ ratings; but possible explanations may include the frequent changes in medications
in a short amount of time in inpatient settings, feeling more comfortable with their children
receiving medications at home where parents can monitor, or unreasonably high
expectations for improvement of complex diagnoses such as bipolar disorder with therapy
only. More research needs to be conducted to determine how parents evaluate treatment
success in various treatment settings. Finally, only 46% of the children in the study were
receiving both outpatient medication and therapy at the time of the assessment even though
parents of children in both inpatient and outpatient settings report the combination of
medication and therapy as beneficial. Emerging practice guidelines and research suggest the
combination of psychosocial intervention and medication is often the most effective option
for treating serious mental illness in children and adolescents (27–31).
Limitations
The present study has several limitations. First, service utilization data were based on parent
report, and were not verified by an additional source. Second, even in a large sample of
outpatient utilizers, small cells sizes limited some comparisons. This sample was restricted
to children who were first time users of the participating clinics thus likely to underestimate
service utilization. Finally, these data are cross-sectional. Examination of the patterns,
predictors and child outcomes of service use will require data from the longitudinal portion
of the study currently in process.
Clinical Implications
Data from this sample of outpatient utilizers suggests that use of mental health services for
children begins at a young age, is multimodal, and occurs in multiple service sectors. Thus
the need for inter-service sector coordination is critical to optimize treatment effectiveness
and efficiency. The finding that type of service use is related to non-need factors such as
insurance and race/ethnicity suggests the continued need for research on treatment
disparities. Contrary to the results from studies examining administrative data, we found
children were infrequently receiving just medication (33, 34). However, efforts need to be
made to ensure that clinicians and families are educated about all treatment options since
less than 50% of children are receiving a combination of medication and therapy despite
research findings indicating the effectiveness of combination treatment for many disorders.
Finally, the increased likelihood for hospitalization as youth get older points to the
importance of early mental health prevention and intervention efforts for younger children
starting to exhibit symptoms of mental illness. Early mental health prevention and
intervention efforts in both medical and educational settings, sectors where young children
are commonly seen, may help to divert youth from restrictive treatment settings and to reach
disadvantaged youth who are receiving suboptimal or no mental health treatment.
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Table 1
Lifetime Service Utilization by Modality & Mean Age Treatment Began
Treatment Modality N (%) Age Treatment Began (in years)
Mean (SD)
Intensive Services 80 (11.3) 7.4 (2.3)
    Residential placement/Partial hospitalization/Day treatment program 39 (5.5) 7.7 (2.1)
    Inpatient hospitalization 64 (9.1) 7.7 (2.4)
Outpatient Services 689 (97.5) 6.3 (2.6)
    Psychiatrist 411 (58.1) 7.9 (2.4)
    Pediatrician or family doctor 403 (57.0) 5.8 (2.3)
    Psychologist, social worker, counselor, therapist 572 (80.9) 7.1 (2.5)
Alternative Services 47 (6.6) 6.1 (2.8)
    Religion-based treatment 25 (3.5) 5.8 (2.8)
    Acupuncturist/Chiropractor 6 (0.8) 5.7 (2.3)
    Self-help Groups/Respite Care 20 (2.8) .03 (0.2)
School Services 361 (51.1) 7.0 (2.1)
    Specialized school 49 (6.9) 7.0 (2.4)
    Special classroom 102 (14.4) 6.8 (1.8)
    Special help in regular classroom 171 (24.2) 6.7 (2.0)
    Counseling/therapy at school 232 (32.8) 7.5 (2.0)
Received Intensive & Outpatient Services 78 (11.0) 5.4 (2.5)
Received Intensive & School Services 51 (7.2) 5.6 (2.2)
Received Outpatient & School Services 351 (49.6) 5.6 (2.2)
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Table 3
Multivariate Results examining factors associated with Lifetime Inpatient Utilization and Outpatient
Treatments
Was the child ever hospitalized?
Total Model X2=33.373, p<.001, R2= 0.101
Step 1 X2=18.704, p=.001, R2= 0.057
B Wald Chi-Square p value
White only race* 0.212 0.471 .493
Sex 0.199 0.497 .481
Age 0.285 16.040 <.001
Medicaid only insurance −0.300 1.003 .317
Step 2 ∆ X2= 14.669, p<.001, ∆ R2=0.044
CGAS score −0.042 9.465 .002
More than one current diagnosis 0.495 1.455 .228
Did the participant receive therapy only in their lifetime?
Total Model X2=29.002, p<.001, R2= 0.059
Step 1 X2=26.192, p<.001, R2= 0.053
B Wald Chi-Square p value
White only race −0.412 4.715 0.030
Sex 0.461 6.510 0.011
Age −0.118 6.867 0.009
Medicaid only insurance −0.381 3.976 0.046
Step 2 ∆ X2= 2.810, p=.245, ∆ R2=0.006
CGAS score 0.014 2.469 0.116
More than one current diagnosis 0.023 0.011 0.916
Did the participant receive medication only in their lifetime?
Total Model X2=11.083, p=0.086, R2= 0.028
Step 1 X2=4.913, p=0.296, R2= 0.012
B Wald Chi-Square p value
White only race 0.289 1.351 0.254
Sex −0.458 3.500 0.061
Age 0.002 0.001 0.978
Medicaid only insurance −0.247 1.082 0.298
Step 2 ∆ X2= 6.170, p=0.046, ∆ R2=0.016
CGAS score 0.028 6.022 0.014
More than one current diagnosis 0.299 1.138 0.286
Did participant receive therapy and medication in their lifetime?
Total Model X2=36.086, p=0.005, R2= 0.068
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Step 1 X2=25.313, p<0.001, R2= 0.048
B Wald Chi-Square p value
White only race 0.212 1.374 0.241
Sex −0.195 1.309 0.252
Age 0.134 10.313 0.001
Medicaid only insurance 0.544 9.632 0.002
Step 2 ∆ X2= 10.773, p=.005, ∆ R2=0.020
CGAS score −0.027 9.945 0.002
More than one current diagnosis −0.105 0.064 0.801
*
Coding of variables includes: race: 0=other race, 1= white only; sex variable 0=male, 1=female; insurance variable 0=Medicaid only, 1=other
insurance coverage; CGAS: lower scores are indicative of poorer functioning (0–100); comorbid diagnoses variable: 0= no comorbid diagnoses, 1=
yes comorbid diagnoses.


































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Mendenhall et al. Page 18
Table 5
Characteristics and Benefit of Inpatient & Outpatient Service Utilization based on Caregiver Report
Lifetime inpatient treatment
Total youth with admissions 65 (9.2%)
Mean number of hospitalizations 2.3 (s.d=3.1)
Most recent inpatient treatment
Median length of stay (days) 5.0 days
Treatment received during most recent hospitalization
    Medication Only 7 (10.8)
    Therapy Only 18 (27.7)
    Medication and Therapy 9 (13.8)
    No Treatment Reported by parent 11 (16.9)
    Parent unsure of all treatments child received 20 (30.8)
How much child benefited from Medication Only?
      Not at all 2 (28.6)
      Some 4 (57.1)
      A lot 0 (0)
      Unknown 1 (14.3)
How much child benefited from Therapy Only?
      Not at all 1 (5.6)
      Some 14 (77.8)
      A lot 3 (16.7)
How much child benefited from Medication and Therapy?
      Not at all 1 (11.1)
      Some 5 (55.6)
      A lot 3 (33.3)
Current outpatient treatment
Number of outpatient professionals 1.2 (s.d=0.7)
Current Treatment
    Medication Only 188 (26.6)
    Therapy Only 247 (34.9)
    Medication and Therapy 108 (15.3)
    Evaluation Only 42 (5.9)
    No Ongoing Current Treatments Reported by Parent 99 (14.0)
    Parent Unsure of All Types of Current Treatments or Information Unable to be obtained 23 (3.3)
How much child benefited from Medication Only?
      Not at all 24 (12.8)
      Some 86 (45.7)
      A lot 70 (37.2)
      Unknown 8 (4.3)
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How much child benefited from Therapy Only?
      Not at all 61 (24.7)
      Some 121 (49.0)
      A lot 44 (17.8)
      Unknown 21 (8.5)
How much child benefited from Medication and Therapy?
      Not at all 7 (6.5)
      Some 55 (50.9)
      A lot 37 (34.3)
      Unknown 10 (9.2)
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